MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber’s hereditary optic neuropathy in healthy MtDNA mutations carriers
MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber’s hereditary optic neuropathy in healthy MtDNA mutations carriers
Pascal Reynier, Christophe Orssaud
Journal
Metabolomics
Topics
Mitochondrial Function and Pathology
article
MetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber’s hereditary optic neuropathy in healthy MtDNA mutations carriers
Pascal Reynier, Christophe Orssaud
article en
Abstract
No abstract available for this paper.
Publication Tag
MetabolomicsVol. 21(5)
Institutions
Centre National de la Recherche Scientifique (FR), Inserm (FR), Hôpital Européen Georges-Pompidou (FR), Centre Hospitalier Universitaire d'Angers (FR), Université d'Angers (FR)